VINC

0.1475

3.15% -0.0048

Vorhandelsmarkt: .13 -0.0175 -11.86%

Vincerx Pharma Inc (VINC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$0.1523

Offen:

$0.1507

24-Stunden-Volumen:

2.30M

Relative Volume:

0.35

Marktkapitalisierung:

$5.38M

Einnahmen:

Nettoeinkommen (Verlust:

$-48.85M

KGV:

-0.0639

EPS:

-2.31

Netto-Cashflow:

$-46.25M

1W Leistung:

-13.59%

1M Leistung:

-28.78%

6M Leistung:

-77.31%

1J Leistung:

-86.21%

1-Tages-Spanne:

$0.1404

$0.152

1-Wochen-Bereich:

$0.1395

$0.1743

52-Wochen-Spanne:

$0.1395

$9.3722

Vincerx Pharma Inc Stock (VINC) Company Profile

Firmenname

Vincerx Pharma Inc

Sektor

Healthcare (1176)

Branche

Biotechnology (685)

Telefon

650-800-6676

Adresse

260 SHERIDAN AVENUE, PALO ALTO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

VINC's Discussions on Twitter

Vergleichen Sie VINC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VINC Vincerx Pharma Inc	0.1475	5.38M	0	-48.85M	-46.25M	-2.31
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-01-14	Eingeleitet	H.C. Wainwright	Buy
2021-12-23	Eingeleitet	Cantor Fitzgerald	Overweight
2021-11-01	Eingeleitet	SVB Leerink	Outperform
2021-09-13	Eingeleitet	Laidlaw	Buy
2021-08-25	Eingeleitet	B. Riley Securities	Buy

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Jan 21, 2025

Vincerx Pharma enters at-the-market equity offering deal - MSN

Jan 21, 2025

Vincerx Pharma enters at-the-market equity offering deal By Investing.com - Investing.com UK

Jan 21, 2025

Jan 17, 2025

Vincerx Pharma ends sales agreement, approves reverse stock split - MSN

Jan 17, 2025

Jan 14, 2025

VINC Stock Touches 52-Week Low at $0.17 Amid Market Challenges - Investing.com UK

Jan 14, 2025

Jan 10, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders - GlobeNewswire Inc.

Jan 10, 2025

Jan 08, 2025

Investor law firms question biotech merger's 'fairness' - The Business Journals

Jan 08, 2025

What Did We Find About Insider Trading At Vincerx Pharma Inc (NASDAQ: VINC)? - Stocks Register

Jan 08, 2025

Jan 07, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders - Stockhouse Publishing

Jan 07, 2025

Jan 06, 2025

VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc.VINC - Marketscreener.com

Jan 06, 2025

Jan 05, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders - Stockhouse Publishing

Jan 05, 2025

Jan 03, 2025

Vincerx Pharma Inc (NASDAQ: VINC): On Track To A Higher Share Price - Stocks Register

Jan 03, 2025

Jan 01, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders - The Malaysian Reserve

Jan 01, 2025

Dec 31, 2024

$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerVINC, VCSA, MRNS, MHLD - Markets Insider

Dec 31, 2024

Dec 30, 2024

VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders - Business Wire

Dec 30, 2024

Stock market today: Intrusion surged by 123.33% while Snow Lake Resources plunged by 21.88% in early trading - Business Upturn

Dec 30, 2024

Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Dec 30, 2024

Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish - MSN

Dec 30, 2024

Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 30, 2024

Dec 27, 2024

Psyence Biomed Announces Closing of $2.0 Million Private Placement - The Manila Times

Dec 27, 2024

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - GlobeNewswire

Dec 27, 2024

Dec 24, 2024

VINC Stock Touches 52-Week Low at $0.18 Amid Market Challenges - Investing.com UK

Dec 24, 2024

FDA Approvals News Live Feed - StockTitan

Dec 24, 2024

Dec 15, 2024

Canadian Solar (NASDAQ:CSIQ) Shares Gap Up – Here’s What Happened - Defense World

Dec 15, 2024

Bicycle Therapeutics (NASDAQ:BCYC) Shares Gap Down Following Analyst Downgrade - Defense World

Dec 15, 2024

Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update - Defense World

Dec 15, 2024

WaFd, Inc (NASDAQ:WAFDP) Short Interest Down 23.6% in November - Defense World

Dec 15, 2024

Vinci Partners Investments Ltd. (NASDAQ:VINP) Sees Significant Growth in Short Interest - Defense World

Dec 15, 2024

Dec 14, 2024

Full Stock Market News from 2024-12-14 - StockTitan

Dec 14, 2024

Dec 05, 2024

Vincerx Pharma announces workforce reduction of 55%, cost-control measures - Yahoo Finance

Dec 05, 2024

Dec 04, 2024

VINC Stock Touches 52-Week Low at $0.24 Amid Market Challenges - Investing.com UK

Dec 04, 2024

Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Asianet Newsable

Dec 04, 2024

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of Vip943 - Marketscreener.com

Dec 04, 2024

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 - GlobeNewswire

Dec 04, 2024

Vincerx Pharma Reports Promising Cancer Drug Results, Explores Strategic Options Amid Cost Cuts - StockTitan

Dec 04, 2024

Nov 28, 2024

DelveInsight Business Research, LLP: Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - finanznachrichten.de

Nov 28, 2024

Nov 26, 2024

Companies To Watch: Terns Pharmaceuticals - Life Science Leader Magazine

Nov 26, 2024

Nov 25, 2024

Vincerx Pharma gets extension to meet Nasdaq listing criteria - Investing.com

Nov 25, 2024

Vincerx Pharma gets extension to meet Nasdaq listing criteria By Investing.com - Investing.com UK

Nov 25, 2024

Nov 20, 2024

Recursion Completes Exscientia Merger, Creates AI Drug Discovery Powerhouse with $20B+ Pipeline - StockTitan

Nov 20, 2024

Nov 16, 2024

Leerink Partnrs Weighs in on Vincerx Pharma FY2024 Earnings - Defense World

Nov 16, 2024

Nov 14, 2024

ARMISTICE CAPITAL, LLC Expands Stake in Vincerx Pharma Inc - GuruFocus.com

Nov 14, 2024